According to the Spanish Association of Cardiology, there has been an increasing number of urgent transplants and medical devices to support said transplants in the last years. Want to know more? Visit our page!

According to the Spanish Association of Cardiology, there has been an increasing number of urgent transplants and medical devices to support said transplants in the last years. Want to know more? Visit our page!
In this webinar, we will be providing you with information about the UK MHRA Medical Devices & IVDs registration process registration
The 6th annual Conference on New Medical Devices Regulations organized by the (EAAR) on the 2nd and 3rd of February 2022 will cover many of the topics of high relevance in the medical devices industry. Want to know more? Visit our page!
The EU regulators agreed to introduce a new set of tools to improve the EU health security coordination before and during crises by reinforcing the management of disruptions due to the scarcity of medicinal products. Want to know more? Visit our page!
The French competent authority (ANSM) has published information for medical devices containing COBALT. The ANSM informs manufacturers that as of October 1, 2021, cobalt will need to be clasified differently. Want to know more? Visit our page!
We met with over 400 manufacturers from more than 50 countries in MEDICA’s halls. Here are the latest news and insights we got from medical manufacturers.
In this article we give you an overview about the MDR requirements that a legacy device must met to be considered compliant.
The Commission Regulation (EU) 2020/2160 has restricted the use of Octylphenol ethoxylate in Medical Devices and In-Vitro Diagnostic Medical Devices from December 22, 2023, onwards. Want more details? Visit our page!
The BSI announced in June of 2021 updates concerning certificates issued for medical devices. Do you want to know how these changes will affect manufacturers and their industries? Visit Our Website.
The French CA together with the ANSM has published a management procedure to support the market operators and prevent a shortage of medical devices and in- vitro diagnostic devices.